Showing posts with label Anita Wagner. Show all posts
Showing posts with label Anita Wagner. Show all posts

Wednesday, September 05, 2012

Socialized Healthcare 8: Anita Wagner on UHC and Medicines

* This is the continuation of my discussion on the AIM lectures last Monday, September 03.  Here is the earlier discussion, Socialized Healthcare 7: Degnan and Wagner on ICIUM and UHC.

Dr. Anita Wagner presented a paper on Universal Coverage or Universal HealthCare (UHC) as used here in the Philippines or other countries. The three questions on expanding healthcare coverage are: (a) extend to non-contributors to the fund, the very poor? (b) expand HC services? and (c) reduce cost and mandatory fees?


I believe in UHC, that everyone, from the poor to the rich, young and old, should have one form of health insurance that can cover both outpatient and hospitalization services. But I do not believe that it is only the government, or mainly the government, that should provide such service. I believe there is a big role for both corporate and civil society provision of healthcare at various levels: community or village, work place and offices, schools and universities. Just give the people various options and choices where and what kind of HC coverage at different price packages would satisfy their personal and household needs.

The medicines aspect of HC. The share of the "pharmerging" (emerging and industrializing economies' consumption of pharmaceutical products) markets to global medicines spending is rising, from only 14 percent of total world demand in 2006, to 20 percent last year, and projected to grow to 30 percent by 2016.

Table below shows that almost 30 percent of total HC spending in low-income countries goes to medicines alone, and only 18.2 percent for high incomes ones.



I think the main reason why the poor has a high percentage of their household healthcare spending  that goes to medicines is because they have no health insurance for outpatient services other than those offered by the nearby government clinic or hospital. For instance, when they have a headache or prolonged fever or bad stomach, among the first things they do is to buy medicines that they see are heavily advertised in tv, radio, billboards and newspapers or magazines. Or those that are recommended by their neighbors, family members and friends. They do not go to private clinics and physicians because physician consultation fee alone would be about the equivalent to one or two-day/s work. And if the physician would order a diagnostic test, the cost would soar further. So the solution is not to see a doctor and just self-medicate. So spending for professional fee and for diagnostic test/s is zero or near zero, the denominator is low, and that raises the share of medicines (the numerator) to total household health spending.

Below, the same story, that spending for medicines dominate the total household healthcare spending. And I offer the same explanation above why this is so. Low chart, same medicines, different cost. Naturally. Why? 


The same way that the price of soda (Coke or Pepsi, etc.) would vary from an ordinary variety (or "sari-sari") store to convenience store to a cheap restaurant to a fine dining resto to a hotel. A bottle of an 8 oz soda for instance can range from P8 to P70 depending on where one would buy the soft drink.

The price of medicines for the same molecule, same dosage, from the same manufacturer, can vary from one drugstore or pharmacy to another. A drugstore in a low-rental place, no air-conditioner, no licensed pharmacist, not paying multiple taxes, can sell medicines at very low price. A drugstore or pharmacy in a high-end mall, fully air-conditioned, has several licensed pharmacists, and complies with various/multiple taxes and regulatory fees, will have to pass on those costs to the price of their medicines. Hospitals will have additional costs to charge when they dispense medicines to their confined patients.

Tuesday, September 04, 2012

Socialized Healthcare 7: Degnan and Wagner on ICIUM and UHC

Healthcare is a very important issue for many people around the planet. That is why emotional arguments are often linked with quantitative and political discourses. The belief or motto that "health is a right and an entitlement from the state" often clouds if not erases the other side of the equation that health is also a personal and parental/guardian/civil society responsibility.

Yesterday, I attended a seminar at the Asian Institute of Management (AIM) by two eminent speakers from Harvard Medical School (HMS) and World Health Organization (WHO) consultants.

Dr. Ross-Degnan, Sc.D. (left photo), an Associate Professor at the Department of Ambulatory Care and Prevention (DACP) at HMS and Director of Research at Harvard Pilgrim Health Care, spoke on Improving Medicines Access and Use: Highlights from the International Conference on
Improving Use of Medicines (ICIUM 2011).

Dr. DegNan co-founded the International Network for Rational Use of Drugs (INRUD) in 1990, a global network of academics, health managers, and policymakers involved in developing and testing interdisciplinary interventions to improve use of medicines. He is a consultant at the WHO on issues related to access to and appropriate use of medicines, and pharmaceutical sector monitoring and evaluation. 

The second speaker was Dr. Anita Wagner (above, right photo), an Assistant Professor in the Department of Ambulatory Care and Prevention (DACP) at HMS and Harvard Pilgrim Health Care. She has a doctorate in epidemiology from Harvard School of Public Health and a doctorate in clinical pharmacy from the Massachusetts College of Pharmacy and Allied Health Sciences. For the WHO Collaborating Center in Pharmaceutical Policy, she leads the global Medicines and Insurance Coverage (MedIC) Initiative. Yesterday, she spoke on Universal Coverage and Medicines: Why Focus on Value?

A staff of Dr. Kenneth Hartigan-Go of AIM, David Teh, sent me the powerpoints today. Thanks David. Dr. Degnan's presentation is about 30 slides, I will show only about half of them below.


Improving use of medicines (IUM) I think is the other term for rational use of medicines (RUM). The latter is used here by the DOH and even by WHO Philippine Office. Right, even if medicines are heavily subsidized by the government, or even freely available, a patient should not over-dose or over-extend taking the medicines simply because they are cheap or free. There are serious long term adverse effects like anti-microbial resistance (AMR) where the body or a disease has gotten used to certain medicines and treatment and simply multiply or evolve into more dangerous diseases even if the patient is taking the necessary medications. The chart on supply and demand of medicines by Dr. Degnan is nice. I think it's simple enough.

Dr. Degnan gave a background about the ICIUM, it holds the conference every seven years. So the next conference would be sometime in 2018. And from 2003 to 2007, there was marginal improvement in policies and implementation of countries to improve use of medicines.


Below are the series of recommendations for each sector or stakeholder. I like the one mentioning the role of think tanks. We don't have much of such stuff here in the Philippines. We instead have dozens or hundreds of advocacy NGOs and people's organizations and cooperatives with definite positions on certain issues that are often not refined or updated with the changing times.

Then I like the mention or emphasis on multi-stakeholder collaboration, the unintended adverse effects of government intervention in pricing of medicines, like the current drug price control and mandatory 20 percent discount to senior citizens and persons with disabilities (PWDs).